Premium
Management of co‐morbid anxiety and alcohol disorders: parallel treatment of disorders
Author(s) -
OEI TIAN P. S.,
LOVEDAY WILLIAM A. L.
Publication year - 1997
Publication title -
drug and alcohol review
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.018
H-Index - 74
eISSN - 1465-3362
pISSN - 0959-5236
DOI - 10.1080/09595239800187441
Subject(s) - anxiety , panic disorder , psychiatry , alcohol dependence , alcohol use disorder , anxiety disorder , generalized anxiety disorder , alcohol abuse , psychology , alcohol , clinical psychology , medicine , biochemistry , chemistry
Co‐morbid alcohol‐related disorders and anxiety disorders have been found to occur in alcohol treatment populations, anxiety treatment populations and the general community. People suffering from co‐occurring alcohol‐related and anxiety disorders are more prone to relapse to alcohol abuse, and more likely to re‐enter the treatment system for either disorder than sufferers of either disorder without a co‐morbid disorder. To review the current state of the management of this disorder, evidence of the prevalence of this co‐morbid condition in clinical and community populations is examined, then the theoretical mechanisms that might explain this connection are reviewed. A comparison of the few treatment studies of co‐morbid alcohol and anxiety disorders shows a limited number of pharmacological treatment trials and no psychotherapy outcome trials. This review shows that it is no longer sustainable to conceptualize co‐morbidity of alcohol and anxiety disorders as a unitary concept, i.e. lumping alcohol‐related and anxiety disorders as one global condition, but as separate distinct combinations of particular anxiety disorders, e.g. alcohol dependence and panic disorder, alcohol dependence and generalized anxiety disorder. The recommended treatment approach, supported by the evidence, is to offer separate and parallel therapy for the alcohol‐related and anxiety disorder, until empirical evidence from treatment outcome studies suggest otherwise. There is an urgent need to conduct treatment outcome research for the subtypes of co‐morbid alcohol and anxiety disorders.